Asia-Pacific Drug Delivery Market, By Product (Semi-Solid Formulation, Liquid Formulation, Solid Formulation, Transdermal Products), Route of Administration (Dermal Drug Delivery, Opthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), End Use (Hospitals and Clinics, Burn Centers, Research Institutes, Home Care, Others) – Industry Trends and Forecast to 2029.
Asia-Pacific Drug Delivery Market Analysis and Size
The creation of new materials or carrier systems for efficient therapeutic medication delivery constitutes a large area of research in the field of drug delivery. Drug delivery techniques that are frequently used include controlled, targeted, and steady drug delivery. Since the development of medical application systems, a variety of drugs are being used to treat a variety of diseases through the administration of various conventional drug delivery dosage forms, such as solutions, lotions, mixtures, creams, pastes, ointments, solutions, powders, suppositories, injections, pills, immediate-release capsules and tablets, etc.
Data Bridge Market Research analyses that the drug delivery market which was USD 263897.56 million in 2021, would rocket up to USD 473112.83 million by 2029, and is expected to undergo a CAGR of 7.57% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Drug Delivery Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Semi-Solid Formulation, Liquid Formulation, Solid Formulation, Transdermal Products), Route of Administration (Dermal Drug Delivery, Opthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery), End Use (Hospitals and Clinics, Burn Centers, Research Institutes, Home Care, Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
GSK Plc. (U.K.), Galderma (Switzerland), Valeant Pharmaceuticals (Canada), Hisamitsu Pharmaceuticals Co. Inc. (Japan), Cipla Inc. (India), Glenmark (India), Johnson & Johnson Private limited (U.S.), Novartis AG (Germany), Bayer AG (Germany), Crescita Therapeutics Inc. (Canada), Biofarmitalia S.R.L (Italy), Pharmatek Laboratories Inc. (U.S.), Skin Visible Pharmaceuticals, Inc. (U.S.), Mylan N.V. (U.S.), Pocono Coated Products LLC (U.S.), SAMYANG HOLDINGS CORPORATION (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Tropical drug delivery is the application of medicine to a specific area of the body, typically the skin, mucous membranes, or body surface, to treat illnesses. It is regarded as the best method for treating a localised problem thoroughly. Drugs given through these results penetrate the skin deeply and are more effectively absorbed. These medications are used to treat a variety of ailments, including viral, bacterial, and fungal infections as well as inflammation, warts, and dermatological problems.
Drug Delivery Market Dynamics
Drivers
- Increasing prevalence of skin diseases
The market will be driven by the rising incidence of skin diseases, while the high technological development in the segment of tropical drug delivery, the rising incidence of burn injuries, the rising incidence of diabetic patients, and the rising geriatric population are the factors propelling the market's expansion.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the drug delivery market. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the drug delivery market forward.
- Surge in sales of self-injection devices
The surge in sales of self-injection devices is one of the main causes that is predicted to boost the growth and demand of the injectable medication delivery sector. Additionally, the prevalence of chronic diseases like diabetes and cancer is rising, which is contributing to the expansion of the Asia Pacific market.
Opportunities
The market will continue to expand due to the rising need for injectables in the treatment of a wide range of conditions, such as Wilson's disease, autoimmune diseases, haemophilia, hepatitis C, and cystic fibrosis.
Restraints/Challenges
On the other hand, tropical drug limitation in curing area and negative impact of frequent reimbursement will be restraining the market.
This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Drug Delivery Market
The market for drug delivery is anticipated to benefit from the increased immunisation rates around the globe. Additionally, the anticipated COVID-19 pandemic third wave with novel viral strains will raise attention on therapeutic research and drug delivery, driving market expansion.
Asia Pacific Drug Delivery Market Scope
The drug delivery market is segmented on the basis of product, route of administration and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Semi-Solid Formulation
- Liquid Formulation
- Solid Formulation
- Transdermal Products
Route of Administration
- Dermal Drug Delivery
- Opthalmic Drug Delivery
- Rectal Drug Delivery
- Vaginal Drug Delivery
- Nasal Drug Delivery
End Use
- Hospitals and Clinics
- Burn Centers
- Research Institutes
- Home Care
- Others
Drug Delivery Market Regional Analysis/Insights
The drug delivery market is analysed and market size insights and trends are provided by country, product, route of administration and end use as referenced above.
The countries covered in the drug delivery market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
China is dominating the market due to increasing number of geriatric population alone with the prevalence of disease like diabetes has raised the demand in market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Drug Delivery Market Share Analysis
The drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to drug delivery market.
Some of the major players operating in the drug delivery market are:
- GSK Plc. (U.K.)
- Galderma (Switzerland)
- Valeant Pharmaceuticals (Canada)
- Hisamitsu Pharmaceuticals Co. Inc. (Japan)
- Cipla Inc. (India)
- Glenmark (India)
- Johnson & Johnson Private limited (U.S.)
- Novartis AG (Germany)
- Bayer AG (Germany)
- Crescita Therapeutics Inc. (Canada)
- Biofarmitalia S.R.L (Italy)
- Pharmatek Laboratories Inc. (U.S.)
- Skin Visible Pharmaceuticals, Inc. (U.S.)
- Mylan N.V. (U.S.)
- Pocono Coated Products LLC (U.S.)
- SAMYANG HOLDINGS CORPORATION (U.S.)
SKU-